Table 3. Population size by age group and site in 2018 and IPD incidence rates per PCV10/PCV13 year during 2011–2018 by age group and site, SpIDnet multicenter study, Europe*.
| Sites |
Population, 2018 |
Annual incidence rate |
|||||||
| 2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
||
| In children <5 y | |||||||||
| CZ | 567,172 | 4.2 | 2.6 | 5.1 | 4.7 | 4.0 | 2.4 | 2.9 | 4.6 |
| DK | 300,798 | 10.1 | 11.6 | 11.2 | 11.7 | 7.5 | 8.1 | 9.6 | 5.7 |
| EN | 3,515,430 | 9.5 | 6.6 | 7.1 | 7.7 | 8.6 | 8.5 | 7.8 | 8.2 |
| FI | 267,686 | 23.8 | 10.5 | 10.9 | 9.0 | 7.8 | 11.5 | 10.8 | 12.8 |
| FR | 2,655,339 | 13.5 | 10.7 | 8.4 | 7.1 | 9.4 | 9.5 | 9.2 | 10.0 |
| IE | 319,296 | 11.5 | 11.8 | 10.7 | 10.2 | 9.7 | 11.8 | 12.6 | 15.0 |
| NL | 217,025 | 7.8 | 4.8 | 3.1 | 7.1 | 6.8 | 5.0 | 7.3 | 7.4 |
| NO | 294,863 | 9.1 | 6.1 | 8.3 | 6.1 | 6.2 | 8.5 | 4.6 | 6.8 |
| SC | 276,862 | 12.1 | 11.5 | 12.2 | 8.9 | 16.1 | 14.8 | 14.9 | 15.2 |
| SE | 604,498 | 7.1 | 4.7 | 5.7 | 5.8 | 3.9 | 5.7 | 4.7 | 6.8 |
| CAT | 359,195 | 41.7 | 38.0 | 25.2 | 24.5 | 30.3 | 26.4 | 25.7 | 28.4 |
| MAD | 320,026 | 23.3 | 16.6 | 16.1 | 15.8 | 18.7 | 17.2 | 18.7 | 17.6 |
| NAV | 30,958 | 20.1 | 14.3 | 28.7 | 33.7 | 42.6 | 24.9 | 28.6 | 29.1 |
| All |
9,729,148 |
12.6 |
9.7 |
8.9 |
8.5 |
9.7 |
9.6 |
9.2 |
9.9 |
| In persons 5–64 y | |||||||||
| CZ | 7,996,011 | 2.9 | 2.3 | 2.7 | 2.0 | 2.6 | 1.8 | 2.4 | 2.5 |
| DK | 4,364,329 | 9.7 | 8.6 | 9.1 | 5.9 | 6.5 | 6.3 | 6.5 | 6.1 |
| EN | 44,769,133 | 5.1 | 4.6 | 4.2 | 4.2 | 5.3 | 5.8 | 5.6 | 5.5 |
| FI | 4,045,396 | 9.9 | 9.2 | 9.1 | 7.9 | 9.0 | 9.1 | 8.7 | 8.3 |
| FR | 35,961,594 | 6.1 | 5.0 | 4.3 | 3.6 | 3.7 | 3.9 | 4.0 | 4.2 |
| IE | 3,864,357 | 4.0 | 3.5 | 3.7 | 3.9 | 3.9 | 4.1 | 4.4 | 5.1 |
| NL | 3,268,467 | 8.6 | 8.2 | 8.2 | 6.7 | 7.7 | 7.0 | 7.1 | 7.5 |
| NO | 4,114,508 | 8.2 | 7.2 | 7.3 | 6.5 | 4.8 | 4.8 | 5.3 | 5.2 |
| SC | 4,135,124 | 6.0 | 5.1 | 6.4 | 4.6 | 6.7 | 8.0 | 7.3 | 6.8 |
| SE | 7,589,976 | 8.3 | 7.9 | 6.9 | 5.6 | 6.8 | 6.1 | 6.4 | 6.8 |
| CAT | 5,767,319 | 7.3 | 7.5 | 6.7 | 5.9 | 6.4 | 6.0 | 7.1 | 7.2 |
| MAD | 5,066,849 | 4.3 | 3.5 | 3.3 | 3.8 | 4.4 | 4.2 | 5.1 | 5.5 |
| NAV | 489,838 | 4.5 | 5.3 | 3.3 | 5.6 | 7.4 | 4.7 | 4.8 | 5.5 |
| All |
131,432,901 |
6.0 |
5.3 |
4.9 |
4.4 |
5.0 |
5.1 |
5.2 |
5.3 |
| In persons >65 y | |||||||||
| CZ | 2,086,617 | 8.0 | 8.2 | 10.2 | 8.3 | 9.9 | 8.3 | 11.7 | 12.5 |
| DK | 1,116,063 | 57.8 | 56.2 | 47.5 | 45.0 | 51.1 | 44.0 | 44.7 | 49.7 |
| EN | 10,831,246 | 23.0 | 22.4 | 21.4 | 21.4 | 26.3 | 29.6 | 30.1 | 29.3 |
| FI | 1,192,077 | 30.3 | 33.6 | 30.2 | 32.5 | 38.0 | 36.1 | 37.2 | 32.9 |
| FR | 9,813,812 | 29.2 | 26.5 | 22.0 | 18.4 | 19.8 | 21.7 | 22.2 | 20.9 |
| IE | 673,362 | 30.1 | 32.2 | 30.1 | 28.6 | 31.2 | 30.1 | 31.9 | 39.4 |
| NL | 809,073 | 51.5 | 53.0 | 53.4 | 42.9 | 53.5 | 50.7 | 46.7 | 52.9 |
| NO | 897,368 | 51.3 | 42.6 | 38.8 | 38.3 | 37.4 | 44.1 | 37.8 | 38.0 |
| SC | 1,026,114 | 24.4 | 25.7 | 30.1 | 22.8 | 31.8 | 34.0 | 37.0 | 28.8 |
| SE | 2,035,711 | 41.6 | 45.5 | 42.1 | 38.8 | 41.1 | 43.7 | 42.6 | 41.7 |
| CAT | 1,417,311 | 27.2 | 32.1 | 34.5 | 29.0 | 33.0 | 31.0 | 34.4 | 37.5 |
| MAD | 1,154,255 | 18.9 | 19.1 | 17.9 | 22.6 | 23.5 | 24.5 | 26.6 | 23.9 |
| NAV | 126,482 | 29.2 | 29.5 | 22.2 | 20.6 | 24.7 | 28.5 | 36.1 | 25.3 |
| All | 33,179,491 | 28.3 | 27.7 | 25.6 | 23.6 | 27.0 | 28.5 | 29.1 | 28.5 |
*CAT, Catalonia; CZ, Czech Republic; DK, Denmark; EN, England; FI, Finland; FR, France; IE, Ireland; IPD, invasive pneumococcal disease; MAD, Madrid; NAV, Navarra; NL, the Netherlands; NOR, Norway; PCV, pneumococcal conjugate vaccine; SC, Scotland; SE, Sweden; SpIDnet, Streptococcus pneumoniae Invasive Disease network.